tiprankstipranks
Trending News
More News >
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market
Advertisement

Extendicare (EXE) Technical Analysis

Compare
217 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 1.42, suggesting Extendicare is a Sell.
Extendicare’s (EXE) 20-Day exponential moving average is 18.95, while Extendicare’s (EXE) share price is C$20.99, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 16.98, while Extendicare’s (EXE) share price is C$20.99, making it a Buy.

Extendicare (EXE) Pivot Points

Nov 29, 2025, 06:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.11
20.36
20.59
20.84
21.07
21.32
21.55
Fibonacci
20.36
20.54
20.65
20.84
21.02
21.13
21.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Nov 29, 2025, 06:33 PM
Period
Simple
Exponential
MA5
20.69Buy
20.67Buy
MA10
20.34Buy
20.08Buy
MA20
18.54Buy
18.95Buy
MA50
16.40Buy
16.98Buy
MA100
14.66Buy
15.50Buy
MA200
13.90Buy
14.05Buy
Extendicare’s (EXE) 10-Day exponential moving average is 20.08, while Extendicare’s (EXE) share price is C$20.99, making it a Buy.
Extendicare’s (EXE) 100-Day exponential moving average is 15.50, while Extendicare’s (EXE) share price is C$20.99, making it a Buy.
Extendicare’s (EXE) stock price is C$20.99 and Extendicare’s (EXE) 50-day simple moving average is 16.40, creating a Buy signal.
Extendicare’s (EXE) stock price is C$20.99 and Extendicare’s (EXE) 100-day simple moving average is 14.66, creating a Buy signal.
Extendicare’s (EXE) stock price is C$20.99 and Extendicare’s (EXE) 200-day simple moving average is 13.90, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Nov 29, 2025, 06:33 PM
Name
Value
Implied Action
RSI (14)
81.50
Sell
STOCH (9,6)
90.75
Sell
STOCHRSI (14)
95.85
Sell
MACD (12,26)
1.42
Sell
ADX (14)
52.52
Sell
Williams %R
-1.70
Sell
CCI (14)
87.20
Neutral
ATR (14)
0.58
-
Ultimate Oscillator
64.42
Neutral
ROC
29.81
Buy
Extendicare’s (EXE) Relative Strength Index (RSI) is 81.50, creating a Sell signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 52.52, creating a Sell signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is 87.20, creating a Neutral signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is 29.81, creating a Buy signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 81.50, which suggests EXE is a Sell.
      What is EXE’s MACD?
      EXE’s MACD is 1.42, which suggests EXE is a Sell.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 20.69, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 18.54, which suggests EXE is a Buy.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 16.40, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 13.90, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -1.70, which suggests EXE is a Sell.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is 87.20, which suggests EXE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis